Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.03
0% from low
Exchange
OTC Link
OS
Borrow rate
0.40%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $7.6M | $9.4M | $12.5M | $25.2M | $31.1M |
| Cost of revenue | $0 | $0 | $0 | $3.0M | $7.2M | $8.8M | $16.7M | $20.9M |
| Gross profit | $0 | $0 | $0 | $4.6M | $2.2M | $3.7M | $8.5M | $10.2M |
| Gross margin | — | — | — | 60.6% | 23.7% | 29.5% | 33.6% | 32.7% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$296.7K | −$257.1K | −$244.8K | $2.2M | −$3.3M | −$5.3M | −$3.3M | −$2.8M |
| EBITDA | −$296.7K | −$257.1K | −$244.8K | $2.5M | −$3.0M | −$4.1M | −$2.0M | −$1.8M |
| Net income | −$272.8K | −$222.8K | −$236.9K | −$278.4K | −$3.1M | −$5.3M | −$4.0M | −$3.5M |
| Net margin | — | — | — | -3.6% | -32.9% | -42.5% | -15.8% | -11.2% |
| EPS (diluted) | -0.02 | -0.01 | -0.01 | -0.00 | -0.03 | -0.04 | -0.02 | -0.01 |
Annual figures · source: Financial Modeling Prep
AYURCANN HLDGS CORP
No one on the platform currently holds AYURF.
No tracked institution reports a position in AYURF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2017-12-11 | 1-for-2reverse |
No one on the platform has traded AYURF yet.
| +0.00% |
| $5M |
| — |
| CRRTFCrescita Therapeutics, Inc. | $0.56 | +0.00% | $10M | — |
| CVSICV Sciences, Inc. | $0.02 | +0.00% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 0.3× historical median P/S.
Fair value ≈ $0.04 · price $0.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$AYURF News - Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs https://www.otcmarkets.com/stock/AYURF/news/Ayurcann-Provides-a-Corporate-Update-Completes-Debt-Settlement-and-Grants-Options-and-RSUs?id=426367
View on StockTwits ↗$AYURF News- AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE https://www.otcmarkets.com/stock/AYURF/news/AYURCANN-REPORTS-RECORD-SALES-IN-Q2-2024-FEATURING-A-141-INCREASE-IN-GROSS-REVENUE?id=431780
View on StockTwits ↗$AYURF - #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd http://www.ayurcann.com/
View on StockTwits ↗$AYURF News- AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE https://www.otcmarkets.com/stock/AYURF/news/AYURCANN-REPORTS-RECORD-SALES-IN-Q2-2024-FEATURING-A-141-INCREASE-IN-GROSS-REVENUE?id=431780
View on StockTwits ↗$AYURF - #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd http://www.ayurcann.com/
View on StockTwits ↗$AYURF News- AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE https://www.otcmarkets.com/stock/AYURF/news/AYURCANN-REPORTS-RECORD-SALES-IN-Q2-2024-FEATURING-A-141-INCREASE-IN-GROSS-REVENUE?id=431780
View on StockTwits ↗$AYURF News- AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd https://www.otcmarkets.com/stock/AYURF/news/AYURCANN-REPORTS-RECORD-SALES-IN-Q2-2024-FEATURING-A-141-INCREASE-IN-GROSS-REVENUE?id=431780
View on StockTwits ↗$AYURF Investor Presentation - #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd https://ayurcann.com/wp-content/uploads/2023/12/1-Ayurcann-Investor-Presentation-December-3.pdf
View on StockTwits ↗$AYURF Investor Presentation - #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd https://ayurcann.com/wp-content/uploads/2023/12/1-Ayurcann-Investor-Presentation-December-3.pdf
View on StockTwits ↗$AYURF - #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd http://www.ayurcann.com/
View on StockTwits ↗$AYURF News- AYURCANN REPORTS RECORD SALES IN Q1 2024 FEATURING A 249% INCREASE IN GROSS REVENUE https://www.otcmarkets.com/stock/AYURF/news/AYURCANN-REPORTS-RECORD-SALES-IN-Q1-2024-FEATURING-A-249-INCREASE-IN-GROSS-REVENUE?id=422945
View on StockTwits ↗$AYURF News - Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs https://www.otcmarkets.com/stock/AYURF/news/Ayurcann-Provides-a-Corporate-Update-Completes-Debt-Settlement-and-Grants-Options-and-RSUs?id=426367
View on StockTwits ↗$AYURF News - Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs https://www.otcmarkets.com/stock/AYURF/news/Ayurcann-Provides-a-Corporate-Update-Completes-Debt-Settlement-and-Grants-Options-and-RSUs?id=426367
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.